Russian Direct Investment Fund

Wirex and Uzbekistan Direct Investment Fund Sign MoU Supporting Implementation of Blockchain Technology

Retrieved on: 
Wednesday, September 28, 2022

LONDON, Sept. 28, 2022 /PRNewswire/ -- Wirex, a global leader in the blockchain industry, today announced the signing of the Memorandum of Understanding with the Uzbekistan Direct Investment Fund.

Key Points: 
  • LONDON, Sept. 28, 2022 /PRNewswire/ -- Wirex, a global leader in the blockchain industry, today announced the signing of the Memorandum of Understanding with the Uzbekistan Direct Investment Fund.
  • In addition to the partnership, Wirex plans to providefinancial investment for several projects to promote growth within the finance and blockchain sectors, enable 35 million Uzbekistan's to access to the benefits of blockchain technology.
  • The Uzbekistan Direct Investment Fund (UzDIF) is a state-owned fund with a focus on providing long-term capital to leading companies in Uzbekistan with strong potential for growth and high shareholder returns.
  • The Uzbekistan Fund for Reconstruction and Development (UFRD), a sovereign wealth fund, is the sole shareholder of the Direct Investment Fund.

Wirex and Uzbekistan Direct Investment Fund Sign MoU Supporting Implementation of Blockchain Technology

Retrieved on: 
Wednesday, September 28, 2022

LONDON, Sept. 28, 2022 /PRNewswire/ -- Wirex, a global leader in the blockchain industry, today announced the signing of the Memorandum of Understanding with the Uzbekistan Direct Investment Fund.

Key Points: 
  • LONDON, Sept. 28, 2022 /PRNewswire/ -- Wirex, a global leader in the blockchain industry, today announced the signing of the Memorandum of Understanding with the Uzbekistan Direct Investment Fund.
  • In addition to the partnership, Wirex plans to providefinancial investment for several projects to promote growth within the finance and blockchain sectors, enable 35 million Uzbekistan's to access to the benefits of blockchain technology.
  • The Uzbekistan Direct Investment Fund (UzDIF) is a state-owned fund with a focus on providing long-term capital to leading companies in Uzbekistan with strong potential for growth and high shareholder returns.
  • The Uzbekistan Fund for Reconstruction and Development (UFRD), a sovereign wealth fund, is the sole shareholder of the Direct Investment Fund.

eWTP Arabia Capital ranks among Top 50 Best Performers and Rising Stars in China

Retrieved on: 
Thursday, August 11, 2022

The China Fund of Funds Research CentreChina-fof.com, in their 2022 rankings, listed Jerry Lee, Founding and Managing Partner, eWPT Arabia Capital within Top 50 Investors of Direct Investment Funds with Best Performance in 2022 and the firm within Top 30 Best Rising Star Funds in 2022.

Key Points: 
  • The China Fund of Funds Research CentreChina-fof.com, in their 2022 rankings, listed Jerry Lee, Founding and Managing Partner, eWPT Arabia Capital within Top 50 Investors of Direct Investment Funds with Best Performance in 2022 and the firm within Top 30 Best Rising Star Funds in 2022.
  • This recognition places eWTP Arabia Capital firmly alongside premium institutions such as Warburg Pincus, Sequoia China Capital, and Hillhouse Capital.
  • eWTP Arabia Capital is a Saudi Arabia and China based growth stage venture fund manager backed by marquee investors such as eWTP Arabia Capital and the sovereign wealth fund of Saudi Arabia, Public Investment Fund (PIF), and headquartered in Riyadh.
  • Founded in 2020, eWTP Arabia Capital is a growth stage venture fund manager based in Beijing, China and Riyadh, Saudi Arabia.

Kazakhstan becomes the first country outside Russia to authorize Sputnik M vaccine for adolescents

Retrieved on: 
Tuesday, February 22, 2022

Thus, Kazakhstan has become the first country outside Russia to authorize the use of Sputnik M.

Key Points: 
  • Thus, Kazakhstan has become the first country outside Russia to authorize the use of Sputnik M.
    In contrast with some international producers offering their vaccines in the same dosage for both adults and adolescents, the Gamaleya Center has developed Sputnik M specifically for adolescents.
  • Sputnik M is a two-shot vaccine based on the same human adenoviral vectors platform, which is safe and has been widely studied for over 30 years.
  • The only difference between Sputnik M and Sputnik V is a lower concentration of viral particles per dose: Sputnik M for adolescents has 5 times less concentration in comparison with the original Sputnik V in both shots.
  • Russian Ministry of Health registered Sputnik M on November 24, 2021 based on data from clinical trials confirming the high safety and immunogenicity profile of Sputnik M among adolescents.

Sputnik V vaccine granted full permanent approval in Russia

Retrieved on: 
Friday, February 4, 2022

MOSCOW, Feb. 4, 2022 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces that the Russian Sputnik V vaccine against coronavirus has been granted full permanent approval by Russia's Health Ministry. It had previously held temporary emergency use authorization (EUA) from the Russian regulator.

Key Points: 
  • MOSCOW, Feb. 4, 2022 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces that the Russian Sputnik V vaccine against coronavirus has been granted full permanent approval by Russia's Health Ministry.
  • Sputnik V was authorized on August 11, 2020, becoming the world's first vaccine against COVID-19 to be granted emergency use authorization.
  • Sputnik V showed significantly smaller (2.6 times) reduction of virus neutralizing activity against Omicron as compared to reference Wuhan variant than Pfizer vaccine (8.1-fold reduction for Sputnik V in contrast to 21.4-fold reduction for Pfizer vaccine).
  • Sputnik Light is based on recombinant human adenovirus serotype number 26 (the first component of Sputnik V).

Top Russian Colocation Provider IXcellerate Closes Latest Round of Funding to Accelerate Expansion Plans

Retrieved on: 
Tuesday, January 25, 2022

IXcellerate already offers world-class data center facilities and outstanding connectivity level in Russia to cater to both local enterprises and global corporations across multiple industries.

Key Points: 
  • IXcellerate already offers world-class data center facilities and outstanding connectivity level in Russia to cater to both local enterprises and global corporations across multiple industries.
  • As one of the largest carrier-neutral commercial data center operators in Russia, IXcellerate is enabling digitalization in Russia through unrivaled scalability and growth opportunities.
  • IXcellerate has a successful record in developing and managing state-of-the-art data centers in Russia.
  • The company is well-positioned to continue growing as a leading colocation and data center operator; directly enhancing Russia's digital infrastructure.

Venezuela received 7 mn doses of Sputnik Light booster in the biggest one-time global delivery of the one-shot Russian vaccine

Retrieved on: 
Tuesday, December 21, 2021

MOSCOW, Dec. 21, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) today announced 7 million doses of Sputnik Light booster against coronavirus have been shipped to Venezuela becoming the biggest one-time global delivery of the one-shot vaccine.

Key Points: 
  • MOSCOW, Dec. 21, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) today announced 7 million doses of Sputnik Light booster against coronavirus have been shipped to Venezuela becoming the biggest one-time global delivery of the one-shot vaccine.
  • Sputnik Light is based on human adenovirus serotype 26 (the first component of Sputnik V).
  • Recent preliminary study announced by Gamaleya Institute showed that Sputnik Light as a booster significantly increases virus neutralizing activity against Omicron.
  • Sputnik V standalone also induces robust neutralizing antibody response to Omicron variant, which is further strengthened by Sputnik Light booster.

Sistema PJSFC: Sistema increases effective stake in Binnopharm Group to 75.3%

Retrieved on: 
Monday, December 20, 2021

As a result of the transaction, the Corporation's effective stake in Binnopharm Group has increased to 75.3%.

Key Points: 
  • As a result of the transaction, the Corporation's effective stake in Binnopharm Group has increased to 75.3%.
  • On 13 December 2021 the Group exercised its call option to acquire VTB's stake in Sinocom Investments Limited for RUB 9.06 billion.
  • On 28 July 2021, the Group exercised a call option to acquire VTB Bank (PJSC)'s stake in Ristango Holding Limited for RUB 6.7 billion.
  • As a result, Sistema has become the largest shareholder in Ristango Holding Limited and through it also Binnopharm Group, with an effective stake of 75.3%.

Recommendations of EMA and ongoing combo studies support mix&match approach pioneered by Sputnik team to fight COVID

Retrieved on: 
Tuesday, December 7, 2021

Thus efficacy of Sputnik V on 6-8 months is much higher than officially published efficacy of mRNA vaccines.

Key Points: 
  • Thus efficacy of Sputnik V on 6-8 months is much higher than officially published efficacy of mRNA vaccines.
  • Sputnik Light as a booster helps other vaccines to increase their efficacy and has a high safety profile.
  • A study in Argentina on heterogeneous regimens combining Sputnik Light and vaccines produced by AstraZeneca, Sinopharm, Moderna and Cansino has demonstrated Sputnik Light is an effective universal booster.
  • RDIF reiterates its offer to producers and countries to join efforts in protecting population through supplies of Sputnik V and Sputnik Light and their combination with other vaccines."

RDIF ready to provide the one-shot Sputnik Light vaccine and Sputnik M vaccine (for adolescents) as it develops strategic cooperation with partners in India to fight COVID

Retrieved on: 
Monday, December 6, 2021

Today India is the leading production hub for Sputnik V and Sputnik Light vaccines.

Key Points: 
  • Today India is the leading production hub for Sputnik V and Sputnik Light vaccines.
  • A major partner of RDIF, Dr. Reddy's Laboratories, has conducted additional clinical trials of Sputnik Light in India.
  • It has become a new member of the Sputnik vaccines family and is offered to international markets joining Sputnik V and Sputnik Light.
  • We are ready to offer the Sputnik Light vaccine and the Sputnik M vaccine for adolescents to support strong herd immunity in India and continue saving millions of lives."